Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ming-fan Ye, Dong Lin, Wu-jin Li, Hai-peng Xu & Jing Zhang. (2020) MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1. Cancer Management and Research 12, pages 7131-7142.
Read now
Read now
Articles from other publishers (31)
Miaomiao Yu, Yueren Fan, Yihang Zhao & Yu Tang. (2023)
MicroRNA
‐140‐3p inhibits proliferation and promotes apoptosis in non‐small cell lung cancer by targeting
MDIG
. Environmental Toxicology.
Crossref
Crossref
Yanyan Luo, Yun Yang, Cong Yang, Chuanyin Li, Ronggui Hu, Wujun Geng, Xianhui Kang & Hai Lin. (2023)
UBE3A
and
MCM6
synergistically regulate the proliferation and migration of lung adenocarcinoma cells
. FEBS Open Bio.
Crossref
Crossref
Ahmed I. Abulsoud, Shereen Saeid Elshaer, Ahmed A. El-Husseiny, Doaa Fathi, Nourhan M. Abdelmaksoud, Sherif S. Abdel Mageed, Aya Salman, Mohamed Bakr Zaki, Hesham A. El-Mahdy, Ahmed Ismail, Elsayed G.E. Elsakka, Mai A. Abd-Elmawla, Hussein M. El-Husseiny, Wael S. Ibrahim & Ahmed S. Doghish. (2023) The potential role of miRNAs in the pathogenesis of salivary gland cancer – A Focus on signaling pathways interplay. Pathology - Research and Practice 247, pages 154584.
Crossref
Crossref
Gavin M. Traber & Ai-Ming Yu. (2023) RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 133-154.
Crossref
Crossref
Marie C. Sell, Charmaine A. Ramlogan-Steel, Jason C. Steel & Bijay P. Dhungel. (2023) MicroRNAs in cancer metastasis: biological and therapeutic implications. Expert Reviews in Molecular Medicine 25.
Crossref
Crossref
Atqiya Fariha, Ithmam Hami, Mahafujul Islam Quadery Tonmoy, Shahana Akter, Hasan Al Reza, Newaz Mohammed Bahadur, Md. Mizanur Rahaman & Md Shahadat Hossain. (2022) Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment. Heliyon 8:10, pages e11081.
Crossref
Crossref
Xiaoran Ma, Jibiao Wu, Bin Wang, Cun Liu, Lijuan Liu & Changgang Sun. (2022) Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review). International Journal of Oncology 61:5.
Crossref
Crossref
Ioana Toma, Alina Silvia Porfire, Lucia Ruxandra Tefas, Ioana Berindan-Neagoe & Ioan Tomuță. (2022) A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA. Pharmaceutics 14:7, pages 1482.
Crossref
Crossref
Lin Ru, Xiao-mei Wang & Jun-qi Niu. (2021) The miR-23–27–24 cluster: an emerging target in NAFLD pathogenesis. Acta Pharmacologica Sinica 43:5, pages 1167-1179.
Crossref
Crossref
Fahimeh Varzideh, Urna Kansakar, Kwame Donkor, Scott Wilson, Stanislovas S. Jankauskas, Pasquale Mone, Xujun Wang, Angela Lombardi & Gaetano Santulli. (2022) Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Shahid Karim, Gamal A Gabr, Mohammad Kashif Iqubal & Samar S. A. Murshid. (2021) Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review. Pharmaceutics 13:12, pages 2120.
Crossref
Crossref
Mingxin Liu, Hong Wu, Yiqiang Liu, Yan Tan, Songtao Wang, Shaohua Xie, Run Xiang, Jingchen Liang, Ru Zhang, Chuan Xu, Jintao He & Qiang Li. (2021) MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1. Science Progress 104:2, pages 003685042110093.
Crossref
Crossref
Yi Xie, Congyu Xue, Shuai Guo & Lei Yang. (2021) MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis. Analytical Cellular Pathology 2021, pages 1-12.
Crossref
Crossref
Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma & Sang-Soo Lee. (2021) Therapeutic advances of miRNAs: A preclinical and clinical update. Journal of Advanced Research 28, pages 127-138.
Crossref
Crossref
Youwei Pu, Zijing Liu, Cheng Zhong, Xuyu Zhang & Yixi Bao. (2020) Immunomodulatory effects of a polysaccharide from Solanum nigrum Linne through TLR4-MyD88 signaling pathway. International Immunopharmacology 88, pages 106973.
Crossref
Crossref
Peng-Jie Yue, Yuan-Yuan Sun, Yun-Hui Li, Zhen-Ming Xu & Wei-Neng Fu. (2020) MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway. Cellular Signalling 74, pages 109709.
Crossref
Crossref
Yong chen, Hanying Wang, Shuangmei Zhu & Xiang Lan. (2020) miR-483–5p promotes esophageal cancer progression by targeting KCNQ1. Biochemical and Biophysical Research Communications 531:4, pages 615-621.
Crossref
Crossref
Ammad Ahmad Farooqi, Rukset Attar, Uteuliyev Yerzhan Sabitaliyevich, Nada Alaaeddine, Damião Pergentino de Sousa, Baojun Xu & William C. Cho. (2020) The Prowess of Andrographolide as a Natural Weapon in the War against Cancer. Cancers 12:8, pages 2159.
Crossref
Crossref
Ruixuan HUANG, William C. CHO, Yanni SUN & Kei Hang Katie CHAN. (2020) The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis. The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis.
Zheng-Xing Guan, Shi-Hao Li, Zi-Mei Zhang, Dan Zhang, Hui Yang & Hui Ding. (2020) A Brief Survey for MicroRNA Precursor Identification Using Machine Learning Methods. Current Genomics 21:1, pages 11-25.
Crossref
Crossref
Catarina Roma-Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista & Alexandra R. Fernandes. (2020) Gene Therapy in Cancer Treatment: Why Go Nano?. Pharmaceutics 12:3, pages 233.
Crossref
Crossref
Mahmoud Elhefnawi, Zeinab Salah & Bangly Soliman. (2019) The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma. Current Gene Therapy 19:5, pages 290-304.
Crossref
Crossref
Ying Zhang, Wan‐Li Jiang, Jun‐Yuan Yang, Jie Huang, Ganjun Kang, Hai‐Bo Hu & Songpig Xie. (2019) Downregulation of lysyl oxidase‐like 4 LOXL4 by miR‐135a‐5p promotes lung cancer progression in vitro and in vivo. Journal of Cellular Physiology 234:10, pages 18679-18687.
Crossref
Crossref
Ruiling Chen, Gangyang Wang, Ying Zheng, Yingqi Hua & Zhengdong Cai. (2019) Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies. Journal of Cellular and Molecular Medicine 23:4, pages 2280-2292.
Crossref
Crossref
Kuan-Li Wu, Ying-Ming Tsai, Chi-Tun Lien, Po-Lin Kuo & and Jen-Yu Hung. (2019) The Roles of MicroRNA in Lung Cancer. International Journal of Molecular Sciences 20:7, pages 1611.
Crossref
Crossref
Paulina Skupin-Mrugalska. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
123
160
.
Cong Liu, Wei Hu, Lin-Lin Li, Yu-Xuan Wang, Qun Zhou, Feng Zhang, Yi-Yan Song-Yang, Wei Zhu, Cheng-Chao Sun & De-Jia Li. (2018) Roles of miR-200 family members in lung cancer: more than tumor suppressors. Future Oncology 14:27, pages 2875-2886.
Crossref
Crossref
Yusen Zhang & Guoqiang Wang. (2018) MicroRNA‑183 inhibits A375 human melanoma cell migration and invasion by targeting Ezrin and MMP‑9. Oncology Letters.
Crossref
Crossref
Aixian Zheng, Xiaolong Zhang, Yanbing Huang, Zhixiong Cai, Xiaolong Liu & Jingfeng Liu. (2018) Polydopamine-assisted versatile modification of a nucleic acid probe for intracellular microRNA imaging and enhanced photothermal therapy. RSC Advances 8:13, pages 6781-6788.
Crossref
Crossref
William C.S. Cho. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
129
136.e2
.
Jing Wu, Zhihui Sun, Huijie Sun & Yanhua Li. (2017) MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer. Molecular Medicine Reports.
Crossref
Crossref